Delayed Docosahexaenoic Acid Treatment Combined with Dietary Supplementation of Omega-3 Fatty Acids Promotes Long-Term Neurovascular Restoration After Ischemic Stroke
- 27 August 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Stroke Research
- Vol. 7 (6), 521-534
- https://doi.org/10.1007/s12975-016-0498-y
Abstract
Prophylactic dietary intake of omega-3 polyunsaturated fatty acids (n-3 PUFAs) has been shown to remarkably ameliorate ischemic brain injury. However, the therapeutic efficacy of n-3 PUFA administration post-stroke, especially its impact on neurovascular remodeling and long-term neurological recovery, has not been fully characterized thus far. In this study, we investigated the effect of n-3 PUFA supplementation, as well as in combination with docosahexaenoic acid (DHA) injections, on long-term stroke outcomes. Mice were subjected to transient middle cerebral artery occlusion (MCAO) before randomly assigned to four groups to receive the following: (1) low dose of n-3 PUFAs as the vehicle control, (2) intraperitoneal DHA injections, (3) n-3 PUFA dietary supplement, or (4) combined treatment of (2) and (3). Neurological deficits and brain atrophy, neurogenesis, angiogenesis, and glial scar formation were assessed up to 28 days after MCAO. Results revealed that groups 2 and 3 showed only marginal reduction in post-stroke tissue loss and attenuation of cognitive deficits. Interestingly, group 4 exhibited significantly reduced tissue atrophy and improved cognitive functions compared to groups 2 and 3 with just a single treatment. Mechanistically, the combined treatment promoted post-stroke neurogenesis and angiogenesis, as well as reduced glial scar formation, all of which significantly correlated with the improved spatial memory in the Morris water maze. These results demonstrate an effective therapeutic regimen to enhance neurovascular restoration and long-term cognitive recovery in the mouse model of MCAO. Combined post-stroke DHA treatment and n-3 PUFA dietary supplementation thus may be a potential clinically translatable therapy for stroke or related brain disorders.Keywords
Funding Information
- U.S. Department of Veterans Affairs (RX000420, Senior Research Career Scientist Award)
- National Institute of Neurological Disorders and Stroke (NS091175, NS095671)
- American Heart Association (13SDG14570025)
- National Natural Science Foundation of China (81571285, 81100978)
This publication has 77 references indexed in Scilit:
- Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral IschemiaStroke, 2015
- Neurobehavioral and Imaging Correlates of Hippocampal Atrophy in a Mouse Model of Vascular Cognitive ImpairmentTranslational Stroke Research, 2015
- Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHAFrontiers in Aging Neuroscience, 2015
- Inadequate supply of vitamins and DHA in the elderly: Implications for brain aging and Alzheimer-type dementiaNutrition, 2015
- Vascular neural network in subarachnoid hemorrhage.Translational Stroke Research, 2014
- Neurobiology of microglial action in CNS injuries: Receptor-mediated signaling mechanisms and functional rolesProgress in Neurobiology, 2014
- Inflammation in intracerebral hemorrhage: From mechanisms to clinical translationProgress in Neurobiology, 2014
- Hyperglycemia, Acute Ischemic Stroke, and Thrombolytic TherapyTranslational Stroke Research, 2014
- The importance of the ratio of omega-6/omega-3 essential fatty acidsBiomedicine & Pharmacotherapy, 2002
- Vascular niche for adult hippocampal neurogenesisJournal of Comparative Neurology, 2000